Active Ingredient(s): Rifapentine
FDA Approved: * June 22, 1998
Pharm Company: * SANOFI AVENTIS US
Category: Tuberculosis

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".

Priftin Overview

Rifapentine, sold under the brand name Priftin, is an antibiotic used in the treatment of tuberculosis.[2] In active tuberculosis it is used together with other antituberculosis medications.[2] In latent tuberculosis it is typically used with isoniazid.[2] It is taken by mouth.[2] Common side effects include low neutrophil counts in the blood, elevated liver enzymes, and white blood cells in the urine.[3] Serious ...

Read more Priftin Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source:

Recent Priftin Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

  • Tablet: 150mg
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Priftin: (3 results)

Sorted by National Drug Code
  • 0088-2100 Priftin 150 mg Oral Tablet by Sanofi-aventis U.S. LLC
  • 0088-2102 Priftin 150 mg Oral Tablet, Film Coated by Sanofi-aventis U.S. LLC
  • 50090-5063 Priftin 150 mg Oral Tablet, Film Coated by A-s Medication Solutions

Other drugs which contain Rifapentine or a similar ingredient: (1 result)

Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 27 July 2021.

We are committed to your privacy.

Copyright © 2005-2021 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA